PHN logo

Pharmanutra S.p.A. Stock Price

BIT:PHN Community·€480.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

PHN Share Price Performance

€0
-53.70 (-100.00%)
€0
-53.70 (-100.00%)
Price €0

PHN Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

High growth potential with solid track record.

2 Risks
3 Rewards

Pharmanutra S.p.A. Key Details

€127.3m

Revenue

€59.5m

Cost of Revenue

€67.8m

Gross Profit

€50.4m

Other Expenses

€17.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.82
53.26%
13.70%
31.8%
View Full Analysis

About PHN

Founded
2003
Employees
118
CEO
n/a
WebsiteView website
www.pharmanutra.it

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and software for body bioimpedance analysis. The company sells its products through sales representatives, wholesalers, pharmacies, para-pharmacies, agents, distributors, online sales, local partners, and tenders. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.

Recent PHN News & Updates

Recent updates

No updates